Quantcast
Channel: Modern medicine - Erin Bastick, PharmD, RPh
Browsing all 28 articles
Browse latest View live

New diabetes medications help address linked diseases

View Article



Cannabinoid-based drug pipeline grows: 4 ways to prepare

View Article

Cannabinoid-based drug pipeline shows promise

View Article

New therapies show promise in treating diabetes

View Article

How pharma reps impact physician prescribing

A new study led by The University of California researchers and published in JAMA reveals surprising findings.

View Article


Top 5 specialty drug management issues

The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.

View Article

Combination pack approved for breast cancer treatment

FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.

View Article

Drugmaker recalls samples of antiplatelet drug

AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.

View Article


Investigational drug appears beneficial in preventing migraines

Lilly's galcanezumab successful in three phase 3 migraine studies. Here are the findings.

View Article


Pharmaceutical pipeline: Top 4 conditions to watch

View Article

First generic Strattera for ADHD approved

FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.

View Article

Asthma biologic may reduce oral steroid use

A new trial for AstraZeneca’s benralizumab shows surprising results for severe asthma patients.

View Article

FDA gives once-daily HIV therapy go-ahead

FDA approves Isentress at a higher dose for HIV-1 infected patients.

View Article


FDA approves first generic Truvada for HIV

The first generic Truvada for treating and preventing HIV will be available, but when?

View Article

FDA approves EpiPen rival

Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.

View Article


FDA to drug maker: Pull opioid pain drug

Potential public health consquences prompts FDA to request removal of opioid pain medication.

View Article

Evolving hepatitis C pipeline offers hope to patients

Cost burden prompts payers to consider appropriate utilization

View Article


FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosis

FDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients

View Article

New antibiotic approved for acute bacterial skin infections

FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSI.

View Article

New universal companion diagnostic paves the way for precision oncology

FDA approves new diagnostic test for non-small cell lung cancer.

View Article
Browsing all 28 articles
Browse latest View live




Latest Images